Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JU79 | ISIN: US0260401056 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
AMERICAN FILMS INC Chart 1 Jahr
5-Tage-Chart
AMERICAN FILMS INC 5-Tage-Chart
ACCESS Newswire
342 Leser
Artikel bewerten:
(1)

American Films, Inc.: American Films' Subsidary, Facterra, Plays Pivotal Role as a Data Provider in Anti-Piracy Lawsuits Against ISPs

Finanznachrichten News

ST. PETERSBURG, FL / ACCESSWIRE / March 25, 2024 / Facterra LLC, a wholly-owned subsidiary of American Films, Inc. (OTC PINK:AMFL), continues its role as a data provider in an anti-piracy campaign for a significant copyright holder in the film and television industry. This campaign, announced last year, aims to seek damages under the Digital Millennium Copyright Act (DMCA). Facterra assists its clients in combatting digital piracy by identifying and recording data associated with the illegal infringement of their copyrighted content on global BitTorrent networks and generating and issuing essential DMCA or copyright infringement notices.

In support of this anti-piracy campaign, Facterra has contributed to two anti-piracy lawsuits against internet service providers. WideOpenWest Finance LLC faces charges in the US District Court for the District of Colorado (Civil Action No. 1:21-cv-1901-DDD-MEH), while RCN Telecom Services LLC is being pursued in the US District Court for the District of New Jersey (Case No. 3:21-cv-15310-RK-TJB).

"As we confront the pervasive issue of online piracy, American Films remains dedicated to supporting creativity and safeguarding intellectual property," said Craig Campbell, Managing Member of Facterra LLC and Chairman of American Films, Inc. "We're pleased with the progress of our collaborative efforts in this legal campaign against piracy. Leveraging our proprietary technology at Facterra, we're firmly committed to protecting the rights of copyright holders and combating digital fraud."

"American Films is dedicated to serving as a trusted partner in risk mitigation for copyright owners," said John Carty, chief executive officer and chief financial officer of American Films, Inc. "We've worked diligently to provide value for our clients, as demonstrated by these two lawsuits. This marks a pivotal moment in our company's journey as we fulfill our mission to champion copyright holders worldwide, fostering consistent, long-term revenue streams and sustainable shareholder value."

Facterra remains committed to upholding copyright protection and combating digital piracy within the entertainment industry.

About American Films, Inc.

American Films owns, develops, and acquires intellectual property, which it seeks to monetize at higher rates through proprietary technology, rights enforcement, and asset digitization. Its unique proprietary processes and technology include FACTERRA, a web-based evidence gathering program that identifies instances of copyright infringement and allows American Films and others to enforce intellectual property rights. American Films supports the creative process and protects intellectual property in the film and music industries.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations or forecasts of future events and include, but are not limited to, statements regarding anticipated future financial performance, business strategies, potential growth opportunities, market conditions, and other similar matters. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. These risks and uncertainties include, but are not limited to, those factors identified in our filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

American Films Media Contacts

Contact Corporate Communications at info@americanfilms.us

Follow American Films on:

LinkedIn
Twitter
Facebook

SOURCE: American Films, Inc.



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.